Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

718

Participants

Timeline

Start Date

October 1, 2012

Primary Completion Date

December 25, 2017

Study Completion Date

December 25, 2017

Conditions
Primary Open Angle GlaucomaOcular Hypertension
Interventions
PROCEDURE

Primary Selective Laser Trabeculoplasty Treatment Pathway

"Primary Selective Laser Trabeculoplasty Treatment (followed by medications as required) Pathway.~First treatment is SLT, 100 shots of laser over 360 degrees. If this does not reach the target IOP then repeat laser (once only) is given. If IOP not at target additional treatment with all standard medications may be used and ultimately surgery (trabeculectomy ).~All available medical treatments (eye-drops) are permitted according to a pre-specified intervention protocol described in detail in the publicly available trial protocol. This begins with prostaglandin analogues, then beta-blockers followed by alpha agonists or carbonic anhydrase inhibitors. The full range of available doses, treatments and drugs is beyond this short summary."

DRUG

Primary Medical Treatment Pathway

"Primary Medical Treatment Pathway (multiple medications, as required). If IOP not at target additional treatment with all standard medications may be used and ultimately surgery (trabeculectomy ).~All available medical treatments (eye-drops) are permitted according to a pre-specified intervention protocol described in detail in the publicly available trial protocol. This begins with prostaglandin analogues, then beta-blockers followed by alpha agonists or carbonic anhydrase inhibitors. The full range of available doses, treatments and drugs is beyond this short summary."

Trial Locations (1)

EC1V 2PD

Moorfields Eye Hospital, London

All Listed Sponsors
lead

Moorfields Eye Hospital NHS Foundation Trust

OTHER

NCT03395535 - Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension | Biotech Hunter | Biotech Hunter